Salud financiera de hoja de balance de Dechra Pharmaceuticals
Salud financiera controles de criterios 1/6
Dechra Pharmaceuticals tiene un patrimonio de accionistas total de £755.2M y una deuda total de £487.6M, lo que sitúa su ratio deuda-patrimonio en 64.6%. Sus activos y pasivos totales son £1.6B y £814.2M respectivamente. El BAIT de Dechra Pharmaceuticals es de £17.1M, por lo que su ratio de cobertura de intereses es de 0.8. Tiene efectivo e inversiones a corto plazo que ascienden a £74.4M.
Información clave
64.6%
Ratio deuda-patrimonio
UK£487.60m
Deuda
Ratio de cobertura de intereses | 0.8x |
Efectivo | UK£74.40m |
Patrimonio | UK£755.20m |
Total pasivo | UK£814.20m |
Activos totales | UK£1.57b |
Actualizaciones recientes sobre salud financiera
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (£467.9M) de DPH superan a sus pasivos a corto plazo (£164.0M).
Pasivo a largo plazo: Los activos a corto plazo (£467.9M) de DPH no cubren sus pasivos a largo plazo (£650.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de DPH (54.7%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de DPH ha crecido de 57.6% a 64.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de DPH no está bien cubierta por el flujo de caja operativo (13%).
Cobertura de intereses: Los pagos de intereses de la deuda de DPH no están bien cubiertos por el BAIT (0.8x cobertura).